Diabetes drug combo tested in over 2,000 patients
NCT ID NCT06495281
Summary
This study looked at whether adding a new drug called Zemidapa to existing diabetes medications helps control blood sugar better. It followed over 2,000 people with type 2 diabetes for 12 weeks to see if the new combination was effective and safe. The main goal was to see how much it lowered a key blood sugar marker called HbA1c.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Chonnam National University Hwasun Hospital
Hwasun, Jeollanam-do, 58128, South Korea
Conditions
Explore the condition pages connected to this study.